RFS was 7.2 vs. 26.7 months in patients with multinodular HCC vs. uninodular HCC (p < 0.001), 26.8 vs. 12.3 months in treatment-naïve vs. non-treatment naïve patients (p < 0.001) and 21.4 vs. 5.1 months in patients with AFP < 100 ng/mL vs. AFP ≥ 100 ng/mL (p = 0.002) (Figure 4). Here, AFP is linked to hepatocellular carcinoma.